New polypill to tackle cardiovascular disease

Two Australian organisations will work together to develop a new four-in-one tablet, designed to reduce the impact of heart disease and strokeBupa Australia and The George Institute for Global Health have announced they are joining forces to develop a new medication with a fixed-dose combination of commonly used blood pressure and cholesterol lowering medications, along with aspirin.Research has shown

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous New guide on consultation rooms for flu jabs
Next Four trends shaping the pharmacy of 2025